| Elekta’s Executive Management consists of the President and CEO, the Chief Financial Officer, the Chief Operating Officer, the managers of four product areas and the three regions – a total of ten members. The President and CEO oversees the work of the Executive Management and the Executive Management makes jointly decisions after consulting with the team. Executive Management meetings are held one or two days each month. The meetings, with Elekta’s General Counsel acting as secretary, are often held in conjunction with visits to the Group’s various units. Details regarding remuneration of the President and CEO and Executive Management are provided in Note 5 in the annual report 2011/12. |
Executive Management
![]() | Tomas PuuseppBorn: 1955 President and CEO Employed since 1988 Holdings*: 600,000 B-shares, 150,000 B-convertibles |
![]() | Johan SedihnBorn: 1965 Chief Operating Officer Employed since 1993 Holdings*: 80,812 B-shares, 20,203 B-convertibles |
![]() | Gilbert WaiBorn: 1953 Executive Vice President, Region Asia Pacific Employed since 1998 Holdings*: 528,000 B-shares |
![]() | Åsa HedinBorn: 1962 Executive Vice President, Elekta Neuroscience Employed 1994–2000 and since 2007 Holdings*: 1,308 B-shares, 327 B-convertibles |
![]() | Bill YaegerBorn: 1961 Executive Vice President, Elekta Oncology Employed 2000–2008 and since 2011 Holdings*: 4,200 B-shares |
| James P. HoeyBorn: 1958 Executive Vice President, Region North America Employed since 2005 (Founded IMPAC 1990) Holdings*: 6,000 B-shares |
![]() | Todd PowellBorn: 1965 Executive Vice President, Elekta Software Employed since 2005 (Employed at IMPAC since 1992) Holdings*: - |
![]() | Håkan BergströmBorn: 1956 CFO Employed since 2001 Holdings*: 140,052 B-shares, 35,013 B-convertibles |
![]() | John Lapré
Born: 1964 Executive Vice President, Elekta Brachytherapy Employed since 2011 (Employeed at Nucletron since 2009) Holdings*: 5,000 B-shares
|
![]() | Ian AlexanderBorn: 1958 Executive Vice President Region Europe, Africa, Latin America and Middle East Employed since: 2008-2011 and since 2012 Holdings*: 53,332 B-shares |
* Reflects own and related natural or legal holdings in the company according to the insider register held by the Swedish Financial Supervisory Authority per December 17, 2012. | |
| President and CEO | |
| The President and CEO is appointed by the Board of Directors and shall oversee the operational management of Elekta in accordance with the guidelines and directions stated in law, the articles of association and the internal operating instructions. Operational management includes all measures that are not – considering the scope and nature of the Company’s operations – of an unusual nature, of major significance, or are explicitly defined as the responsibility of the Board of Directors. Tomas Puusepp has served as President and CEO of Elekta since May 1, 2005. Born in 1955, he has a total of 30 years of experience in international medical technology. Following studies in engineering and physics and management training at IMD in Lausanne, Switzerland, Tomas Puusepp held various positions at the Research Institute for Atomic Physics, Scanditronix and Ericsson before being employed by Elekta in 1988. Since then, he has held various management positions within the Company, including head of Elekta’s neurosurgery operations, President of Elekta’s subsidiary in North America and global head of Elekta’s sales, marketing and service operations. Tomas Puusepp has no significant assignments outside Elekta. He has no shareholdings or ownership interests in companies with significant business relations with Elekta. Tomas Puusepp’s share and option holding in Elekta is noted in the above table. | |








